Microfluidics-Imaging Platform Detects Cancer Growth Signaling in Minute Biopsy Samples, University of California, Los Angeles (UCLA) Study
ScienceDaily (Nov. 1, 2010) — Inappropriate growth and survival signaling, which leads to the aberrant growth of cancer cells, is a driving force behind tumors. Much of current cancer research focuses on the kinase enzymes whose mutations are responsible for such disregulated signaling, and many successful molecularly targeted anti-cancer therapeutics are directed at inhibiting kinase activity.